TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
161,613
127,136
131,534
64,706
Short Term Investments
-
-
-
-
Total Cash
161,613
127,136
131,534
64,706
Net Receivables
11,064
4,329
4,501
3,050
Inventory
3,268
1,485
1,076
690
Other Current Assets
10,835
6,604
2,299
2,234
Total Current Assets
186,779
139,554
139,410
70,680
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,026
809
747
351
Accumulated Depreciation
-554
-372
-231
-153
Net property, plant and equipment
473
437
517
199
Equity and other investments
-
-
-
-
Goodwill
-
-
-
-
Intangible Assets
24,093
3,100
2,406
1,615
Other long-term assets
639
139
139
125
Total non-current assets
25,205
3,676
3,062
3,049
Total Assets
211,984
143,230
142,472
73,729
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
-
-
-
Accounts Payable
22,744
4,098
7,359
3,126
Taxes payable
-
-
-
-
Accrued liabilities
18,335
6,672
6,087
6,720
Deferred revenues
-
-
-
-
Other Current Liabilities
-
9,224
7,624
7,540
Total Current Liabilities
41,079
13,321
14,983
10,666
Non-current liabilities
Long Term Debt
73,381
-
-
-
Deferred taxes liabilities
-
-
-
-
Deferred revenues
-
-
-
-
Other long-term liabilities
-
-
-
-
Total non-current liabilities
73,381
0
0
0
Total Liabilities
114,460
13,321
14,983
10,666
Stockholders' Equity
Common Stock
240
216
197
178
Retained Earnings
-519,276
-386,659
-309,702
-219,827
Accumulated other comprehensive income
-
-
-
-
Total stockholders' equity
97,524
129,909
127,489
63,063
Total liabilities and stockholders' equity
211,984
143,230
142,472
73,729